Items where authors include "Jani, M."

Article

Lyon, M. orcid.org/0000-0003-4845-1743, Zhao, S.S., Jani, M. orcid.org/0000-0002-1487-277X et al. (132 more authors) (2024) The influence of deprivation in the outcomes of psoriatic arthritis within the UK—utilizing Outcomes of Treatment in Psoriatic Arthritis Study Syndicate (OUTPASS) data. Rheumatology Advances in Practice, 8 (2). rkae051. ISSN 2514-1775

Curry, P.D.K. orcid.org/0000-0003-0013-460X, Morris, A.P. orcid.org/0000-0002-6805-6014, Jani, M. orcid.org/0000-0002-1487-277X et al. (133 more authors) (2024) Psoriatic arthritis: the role of self-reported non-adherence, non-trough drug levels, immunogenicity and conventional synthetic DMARD co-therapy in adalimumab and etanercept response. Rheumatology Advances in Practice, 8 (1). rkae014. ISSN 2514-1775

Curry, P.D.K. orcid.org/0000-0003-0013-460X, Chinoy, H. orcid.org/0000-0001-6492-1288, Jani, M. orcid.org/0000-0002-1487-277X et al. (8 more authors) (2023) The Effect of COVID-19 on Medication Adherence in a Rheumatoid Arthritis (BRAGGSS) and Psoriatic Arthritis (OUTPASS) UK Cohort. The Journal of Rheumatology, 50 (11). pp. 1518-1521. ISSN 0315-162X

Jani, M., Isaacs, J.D., Morgan, A.W. et al. (5 more authors) (2016) High frequency of antidrug antibodies and association of random drug levels with efficacy in certolizumab pegol-treated patients with rheumatoid arthritis: results from the BRAGGSS cohort. Annals of the Rheumatic Diseases. annrheumdis-2015. ISSN 0003-4967